Rici Healthcare Holdings Ltd. (1526) AI Stock Analysis

• Market Cap: HK$1.75B
• Dividend Yield: 4.09%
• Average Volume (3M): 77.27K
• Price to Earnings (P/E): 5.4
• Beta (1Y): 0.36
• Revenue Growth: -3.85%
• EPS Growth: -19.28%
• Country: HK
• Employees: 8,908
• Sector: Healthcare
• Sector Strength: 38
• Industry: Medical - Care Facilities
• EPS (TTM): 0.14
• Shares Outstanding: 1,590,324,000
• 10 Day Avg. Volume: 93,000
• 30 Day Avg. Volume: 77,266
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$1.00
• Price Target Upside: -9.09% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 70 Outperform
• Price Target: HK$1.00 ▼(-9.09% Downside)

Rici Healthcare Holdings Ltd. scores well due to its strong profitability and attractive valuation. However, the decline in revenue growth and high leverage are notable risks. The technical analysis supports a stable outlook, while the absence of earnings call and corporate events data limits further insights.

Rici Healthcare Holdings Ltd. Business Overview & Revenue Model

Company Description

Rici Healthcare Holdings Ltd. (1526) is a leading provider of comprehensive medical and healthcare services in China. The company operates through three main segments: medical examination services, hospital services, and medical consultancy services. Rici Healthcare is dedicated to delivering high-quality healthcare solutions, focusing on preventive care, diagnostic services, and treatment through its network of medical examination centers and hospitals.

How the Company Makes Money

Rici Healthcare Holdings Ltd. generates revenue primarily through its medical examination services, hospital services, and medical consultancy services. The company earns income from providing routine health check-ups, specialized medical tests, and diagnostic services through its medical examination centers. Hospital services contribute to the revenue by offering inpatient and outpatient care, surgical procedures, and specialized medical treatments. Additionally, Rici Healthcare offers medical consultancy services, providing expert guidance and management solutions to other healthcare institutions. Key partnerships with insurance providers and corporate clients also play a significant role in driving revenue, as they bring in a steady flow of patients seeking preventive and diagnostic healthcare services.

Rici Healthcare Holdings Ltd. Financial Statement Overview

Summary

Rici Healthcare Holdings Ltd. demonstrates strong profitability with solid profit margins and return on equity. However, revenue decline and high leverage pose risks. Cash flow management needs improvement to ensure liquidity and growth.

Income Statement

Rici Healthcare Holdings Ltd. shows a strong gross profit margin of 39.9% and a net profit margin of 10.2% for the latest year. Revenue showed a slight decline of 2.3% compared to the previous year, indicating some challenges in maintaining growth. The EBIT margin is healthy at 20.8%, and the EBITDA margin stands at 27.3%, reflecting solid operational efficiency. While profitability remains robust, the recent revenue contraction highlights the need for strategic growth initiatives.

Balance Sheet

The company's debt-to-equity ratio is relatively high at 1.71, indicating leverage that could pose risks if not managed carefully. However, the return on equity is strong at 22.1%, showing effective use of equity capital. With an equity ratio of 27.7%, the company maintains a balanced asset structure, though the high debt level suggests potential volatility in financial stability.

Cash Flow

Rici Healthcare's free cash flow is currently zero, which poses concerns about liquidity and operational cash coverage. The previous year showed a positive operating cash flow to net income ratio of 2.27, indicating healthy cash generation relative to net income in the past. The absence of free cash flow growth in the latest year suggests cash flow management may need attention to sustain operations and fund growth.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.92B	2.99B	2.38B	2.38B	1.93B
Gross Profit	1.17B	1.25B	927.20M	975.22M	580.66M
EBITDA	798.69M	1.07B	572.61M	682.80M	234.75M
Net Income	297.32M	363.80M	290.79M	349.15M	-7.88M
Balance Sheet
Total Assets	4.86B	4.64B	4.57B	4.54B	4.21B
Cash, Cash Equivalents and Short-Term Investments	1.12B	811.21M	720.14M	784.36M	574.86M
Total Debt	2.30B	2.27B	2.30B	2.74B	2.90B
Total Liabilities	3.48B	3.52B	3.66B	3.95B	3.88B
Stockholders Equity	1.35B	1.13B	953.92M	677.50M	505.81M
Cash Flow
Free Cash Flow	584.35M	487.07M	396.33M	356.41M	77.71M
Operating Cash Flow	790.58M	826.29M	706.37M	681.07M	444.63M
Investing Cash Flow	-140.02M	-147.00M	-273.99M	-269.13M	-355.44M
Financing Cash Flow	-351.23M	-592.72M	-495.23M	-193.99M	169.32M

Rici Healthcare Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.10
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Positive. The current price of 1.1 is above the 20-day moving average (MA) of 1.08, above the 50-day MA of 1.08, and below the 200-day MA of 1.16, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.76 is Neutral, neither overbought nor oversold. The STOCH value of 49.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1526.

Rici Healthcare Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1526	70 Outperform	HK$1.75B	5.43	24.13%	4.09%	-3.85%	-19.28%
3689	68 Neutral	HK$642.04M	38.63	1.07%	8.33%	-1.20%	-87.51%
Sector *	60 Neutral	HK$18.24B	4.85	-4.00%	3.35%	9.59%	-23.62%
9906	58 Neutral	HK$906.00M	24.55	5.60%	―	-0.83%	-18.97%
1419	55 Neutral	HK$368.17M	17.54	2.73%	2.89%	-0.69%	―
3869	48 Neutral	HK$949.39M	―	-10.78%	―	-0.95%	-128.35%
3886	48 Neutral	HK$1.83B	―	-6.55%	0.43%	0.04%	-4.88%

Rici Healthcare Holdings Ltd. Corporate Events

Rici Healthcare Updates Nomination Committee Terms

Rici Healthcare Holdings Ltd., incorporated in the Cayman Islands, has revised the terms of reference for its Nomination Committee, which is responsible for board composition and succession planning. The committee’s duties include reviewing board structure, assessing director independence, and recommending appointments to ensure alignment with corporate strategy. This revision aims to enhance governance and strategic alignment, potentially impacting the company’s leadership and operational effectiveness.

Rici Healthcare’s AGM Resolutions Unanimously Approved

Rici Healthcare Holdings Ltd. announced that all resolutions proposed at its Annual General Meeting held on June 19, 2025, were unanimously passed by its shareholders. This includes the re-election of directors, authorization for the board to fix directors’ remuneration, re-appointment of auditors, and mandates related to share allotment and repurchase, indicating strong shareholder support and a stable outlook for the company’s governance and financial strategies.